Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors
Abstract Background In addition to proatherogenic properties, lipoprotein (a) (Lp(a)) has also pro-inflammatory, antifibrinolytic and prothrombogenic features. The aim of the current study was to identify the predictors of functional and morphological properties of the arterial wall in patients afte...
Main Authors: | Andreja Rehberger Likozar, Miran Šebeštjen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Cardiovascular Ultrasound |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12947-023-00313-9 |
Similar Items
-
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors
by: Tina Levstek, et al.
Published: (2023-03-01) -
Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet’s disease
by: Rabia Aydogan Baykara, et al.
Published: (2022-07-01) -
Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease
by: Bianca E. Suur, et al.
Published: (2022-09-01) -
The Association of Proprotein Convertase Subtilisin/Kexin Type 9 to Plasma Low-Density Lipoproteins: An Evaluation of Different Methods
by: Laura Canclini, et al.
Published: (2021-12-01) -
Lipid Parameters and Proprotein Convertase Subtilisin/Kexin Type 9 in Healthy Lebanese Adults
by: Marie-Hélène Gannagé-Yared, et al.
Published: (2022-07-01)